Education
About Us
Working with TipRanks
Follow Us
Esperion Therapeutics (GB:0IIM)
:0IIM
Esperion (0IIM) Ownership Overview
1.75% Insiders
18.64%
Mutual Funds
27.45% Other Institutional Investors
9.75% ETFs
42.41% Public Companies and
Individual Investors
The ownership structure of Esperion (GB:0IIM) stock is a mix of institutional, retail, and individual investors. Approximately 55.84% of the company’s stock is owned by Institutional Investors, 1.75% is owned by Insiders, and 42.41% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 19, 2025 | xxxxxxxxxxxxx | $5232 | |
| Mar 19, 2025 | Sheldon L. Koenig President & Ceo,director | xxxxxxxxxxxxx | $19571 |
| Mar 19, 2025 | Eric Warren Cco | xxxxxxxxxxxxx | $3601 |
| Feb 20, 2025 | xxxxxxxxxxxxx | $20 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $26349 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $423313 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $1848114 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $3308241 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 16,421,901 | Institution | 8.30% | 22,744,333 | |
| 9,915,508 | Institution | 5.01% | 13,732,979 | |
| 8,889,006 | Institution | 4.49% | 12,311,273 | |
| 7,674,549 | Institution | 3.88% | 10,629,250 | |
| 2,125,232 | Institution | 1.07% | 2,943,446 | |
| 1,987,197 | Institution | 1.00% | 2,752,268 | |
| 1,984,040 | Institution | 1.00% | 2,747,895 | |
| 1,816,905 | Institution | 0.92% | 2,516,413 | |
| 1,571,962 | Insider | 0.79% | 2,177,167 | |
| 1,503,746 | Institution | 0.76% | 2,082,688 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 16,421,901 | Institution | 8.30% | 22,744,333 | |
| 8,889,006 | Institution | 4.49% | 12,311,273 | |
| 2,125,232 | Institution | 1.07% | 2,943,446 | |
| 1,987,197 | Institution | 1.00% | 2,752,268 | |
| 1,984,040 | Institution | 1.00% | 2,747,895 | |
| 1,816,905 | Institution | 0.92% | 2,516,413 | |
| 1,041,306 | Institution | 0.53% | 1,442,209 | |
| 554,914 | Institution | 0.28% | 768,556 | |
| 512,125 | Institution | 0.26% | 709,293 | |
| 327,000 | Institution | 0.17% | 452,895 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Esperion Therapeutics (GB:0IIM)?
According to the latest TipRanks data, approximately 27.45% of the company's stock is held by institutional investors, 1.75% is held by insiders, and 42.41% is held by retail investors.
What percentage of Esperion Therapeutics (GB:0IIM) stock is held by institutional investors?
According to the latest TipRanks data, approximately 27.45% of Esperion Therapeutics (GB:0IIM) stock is held by institutional investors.
What percentage of Esperion Therapeutics (GB:0IIM) stock is held by retail investors?
According to the latest TipRanks data, approximately 42.41% of Esperion Therapeutics (GB:0IIM) stock is held by retail investors.
Who owns the most shares of Esperion Therapeutics (GB:0IIM)?
WASATCH FUNDS TRUST owns the most shares of Esperion Therapeutics (GB:0IIM).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.